Search research articles
Contact Us
Filters
Showing results (201-210 of 299) with videos related to
Page
of 30
Sort By:
British Journal of Haematology
|
September 1, 1986
Standardization of T-cell depletion in HLA matched bone marrow transplantation
M J Gilmore, J Patterson, K Ivory, et al.
Leukemia
|
June 1, 1994
Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)
F Frassoni, M Labopin, E Gluckman, et al.
Gene Therapy
|
October 5, 2002
Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy
R F Duarte, F E Chen, M W Lowdell, et al.
Leukemia
|
January 1, 1988
Correlation of immunophenotype with rearrangement of T cell antigen receptor beta and gamma genes in acute lymphoblastic leukemia of adults
J D Norton, D Campana, A V Hoffbrand, et al.
Bone Marrow Transplantation
|
October 21, 2000
Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation
P J Paterson, S R Marshall, B Shaw, et al.
British Journal of Haematology
|
August 1, 1990
Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma
D J Gottlieb, H G Prentice, A B Mehta, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 1983
The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations
I Hann, P Noone, H G Prentice, et al.
Lancet (London, England)
|
July 26, 1980
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia
H G Prentice, J F Smyth, K Ganeshaguru, et al.
Blood
|
November 15, 1989
Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy
D J Gottlieb, H G Prentice, H E Heslop, et al.
Clinical and Experimental Immunology
|
October 1, 1982
Immunological analysis of the skin in graft versus host disease
I A Lampert, G Janossy, A J Suitters, et al.
Page
of 30
Search research articles
Search
Showing results (201-210 of 299) with videos related to
Sort By:
Page
of 30
British Journal of Haematology
|
September 1, 1986
Standardization of T-cell depletion in HLA matched bone marrow transplantation
M J Gilmore, J Patterson, K Ivory, et al.
Leukemia
|
June 1, 1994
Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT)
F Frassoni, M Labopin, E Gluckman, et al.
Gene Therapy
|
October 5, 2002
Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy
R F Duarte, F E Chen, M W Lowdell, et al.
Leukemia
|
January 1, 1988
Correlation of immunophenotype with rearrangement of T cell antigen receptor beta and gamma genes in acute lymphoblastic leukemia of adults
J D Norton, D Campana, A V Hoffbrand, et al.
Bone Marrow Transplantation
|
October 21, 2000
Fatal invasive cerebral Absidia corymbifera infection following bone marrow transplantation
P J Paterson, S R Marshall, B Shaw, et al.
British Journal of Haematology
|
August 1, 1990
Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma
D J Gottlieb, H G Prentice, A B Mehta, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 1983
The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations
I Hann, P Noone, H G Prentice, et al.
Lancet (London, England)
|
July 26, 1980
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia
H G Prentice, J F Smyth, K Ganeshaguru, et al.
Blood
|
November 15, 1989
Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy
D J Gottlieb, H G Prentice, H E Heslop, et al.
Clinical and Experimental Immunology
|
October 1, 1982
Immunological analysis of the skin in graft versus host disease
I A Lampert, G Janossy, A J Suitters, et al.
Page
of 30